Pfizer Inc. (PFE)
25.78
+0.44
(+1.76%)
USD |
NYSE |
Dec 10, 16:00
25.77
0.00 (0.00%)
After-Hours: 18:46
Pfizer Free Cash Flow: 10.38B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| Viking Therapeutics, Inc. | -224.58M |
| Arvinas, Inc. | -- |
| Moderna, Inc. | -2.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.603B |
| Cash from Investing (Quarterly) | -2.43B |
| Cash from Financing (Quarterly) | -2.476B |
| Free Cash Flow Per Share (Quarterly) | 0.7002 |
| Free Cash Flow to Equity (Quarterly) | 4.086B |
| Free Cash Flow to Firm (Quarterly) | 4.695B |
| Free Cash Flow Yield | 7.05% |